Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 8, 2010, Pages 1024-1028

  Rabiu, Kabiru A ^a   Akinola, Oluwarotimi I ^a   Adewunmi, Adeniyi A ^a   Omololu, Olufemi M ^b   Ojo, Temitope O ^b  

^a LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b Lagos Island Maternity Hospital   (Nigeria)

Author keywords

Antenatal care; Diagnosis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ABORTION; ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CIRCUMCISION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENTAL SURGERY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; JAUNDICE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPARA; MULTIVARIATE ANALYSIS; NIGERIA; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCAR FORMATION; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TATTOOING; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COITUS; FEMALE; HEPATITIS B; HEPATITIS B ANTIGENS; HUMANS; NIGERIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES;

EID: 77954856849     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016349.2010.482580     Document Type: Article

References (23)

1. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204. WHO Web site 2009. Available online at: http://www.who.int/ mediacentre/factsheets/fs204/ en/index.html.
2. Lok AS. Chronic hepatitis B.N Engl JMed. 2002;346:1682-1683
3. Lesi OA, Kehinde MO, Anomneze EE. Chronic liver disease in Lagos: a clinicopathological study. Niger Postgrad Med J. 2004;11:91-96
4. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2:50-57
5. Sirisena ND, Njoku MO, Idoko JA, Isamade E, Barau C, Jelpe D, et al. Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau state, Nigeria. Niger Postgrad Med J. 2002;9:7-10.
6. Jombo GT, Egah DZ, Banwat EB. Hepatitis B virus infection in a rural settlement of Nothern Nigeria. Niger J Med. 2005;14:425-428
7. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107.
8. Onakewhor JUE, Offor E, Okonofua FE. Maternal and neonatal seroprevalence of hepatitis B surface antigen (HBsAg) in Benin City, Nigeria. J Obstet Gynaecol. 2006;26:770-772
9. Butterfield CR, Shockley M, San Miguel G, Rosa C. Routine screening for hepatitis B in an Obstetric population. Obstet Gynecol. 1990;76:25-27
10. Salawu L, Murianah HA. Pre-donation screening of intending blood donors for antibodies to infectious agents in a Nigerian tertiary health institution: a pilot study. Afr J Med Sci. 2006;35:453-456
11. Umolu PI, Okafor LE, Orhue P. Human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenaemia (HBsAg) among blood donors in Benin City, Edo state, Nigeria. Afr Health Sci. 2005;5:55-58
12. Kulkarni AG, Aloowooja FO, Wayo GB. Prevalence of hepatitis B surface antigen in northern Nigerian blood donors. Vox Sang. 1986;50:151-153
13. Pierce RL, Smith S, Rowe-West B, Sterritt B. Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina. Arch Pediatr Adolesc Med. 1999:153:619-623
14. Alrowaily MA, Abolfotouh MA, Ferwunah MS. Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol. 2008;14:70-72
15. Obi SN, Onah HE, Ezugwu FO. Risk factors for hepatitis B infetion during pregnancy in a Nigerian obstetric population. J Obstet Gynaecol. 2006;26:770-772
16. Akani CI, Ojule AC, Opurum AC, Ejimele AA. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J. 2005;12:266-270
17. Damale NKR, Lassey AT, Bekoe V. Hepatitis B virus seroprevalence among parturients in Accra, Ghana. Int J Gynecol Obstet. 2005;90:240-241
18. Rumi MA, Begum K, Hassan MS, Hassan SM, Azam MG, Hassan KN, et al. Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg. 1998;59:318-322
19. OgunkunleMO, Oni AA, Odiabo GN, Olaleye OD. Hepatitis B surface antigen (HBsAg) in blood and genital secretions of patients with sexually transmitted diseases in Ibadan, Nigeria. West Afr J Med. 2005;24:206-208
20. Van Duynhoven YT, van de Lar MJ, Schop WA, Rothbath PH, van der Meijden WI, van Loon AM, et al. Prevalence and risk factors for hepatitis B virus infection among visitors to an STD clinic. Genitourin Med. 1997;73:488-492
21. Centre for Disease Control. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection intheUnitedStates. Recommendationoftheadvisorycommittee on immunization practices. Part 1: Immunization of infants, childrenandadolescents.MorbMortalwklyRep.2005;54:1-23.
22. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29:133-139
23. Cowan SA, Bagdonaite I, Qureshi K. Universal hepatitis B screening of pregnant women in Denmark ascertains substantial additional infections: results from the first five months. Euro surveill. 2006;11:ii2969. Available online at: http://www. eurosurveillance.org/ViewArticle.aspx?Articleld=2969